MACCARI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 18.402
AS - Asia 8.249
EU - Europa 7.382
SA - Sud America 1.014
Continente sconosciuto - Info sul continente non disponibili 195
AF - Africa 161
OC - Oceania 40
Totale 35.443
Nazione #
US - Stati Uniti d'America 18.016
SG - Singapore 2.911
IT - Italia 2.201
GB - Regno Unito 2.010
CN - Cina 2.005
HK - Hong Kong 970
BR - Brasile 759
SE - Svezia 692
VN - Vietnam 641
DE - Germania 430
FI - Finlandia 392
BD - Bangladesh 371
FR - Francia 339
UA - Ucraina 320
TR - Turchia 292
KR - Corea 290
RU - Federazione Russa 250
CA - Canada 185
IN - India 143
BG - Bulgaria 129
ID - Indonesia 118
NL - Olanda 114
JP - Giappone 103
MX - Messico 93
AR - Argentina 76
ES - Italia 75
PL - Polonia 62
PK - Pakistan 54
CH - Svizzera 53
IQ - Iraq 51
IE - Irlanda 50
AE - Emirati Arabi Uniti 36
CL - Cile 35
AU - Australia 34
EC - Ecuador 34
MY - Malesia 34
ZA - Sudafrica 34
CO - Colombia 32
IR - Iran 26
SK - Slovacchia (Repubblica Slovacca) 26
TH - Thailandia 26
VE - Venezuela 26
BE - Belgio 25
CZ - Repubblica Ceca 25
EG - Egitto 25
AT - Austria 24
LT - Lituania 24
UZ - Uzbekistan 23
MA - Marocco 21
NP - Nepal 21
SA - Arabia Saudita 21
RS - Serbia 20
CR - Costa Rica 19
DK - Danimarca 19
DZ - Algeria 19
PE - Perù 19
PH - Filippine 19
RO - Romania 19
JM - Giamaica 18
KE - Kenya 18
PT - Portogallo 18
TN - Tunisia 13
BO - Bolivia 12
TW - Taiwan 12
UY - Uruguay 11
GR - Grecia 10
IL - Israele 10
JO - Giordania 10
PY - Paraguay 10
AZ - Azerbaigian 9
KZ - Kazakistan 9
NI - Nicaragua 9
TT - Trinidad e Tobago 9
EE - Estonia 8
HN - Honduras 8
AL - Albania 7
HR - Croazia 7
NG - Nigeria 7
EU - Europa 6
GT - Guatemala 6
HU - Ungheria 6
KW - Kuwait 6
MK - Macedonia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
SY - Repubblica araba siriana 6
CI - Costa d'Avorio 5
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
LB - Libano 5
PS - Palestinian Territory 5
SV - El Salvador 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
OM - Oman 4
PA - Panama 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BS - Bahamas 3
Totale 35.206
Città #
Ashburn 2.361
Singapore 2.107
Santa Clara 1.567
Fairfield 1.536
Southend 1.322
Woodbridge 1.014
Hong Kong 948
Chandler 877
Houston 823
San Jose 793
Council Bluffs 662
Seattle 582
Jacksonville 578
Hefei 542
Cambridge 524
Dearborn 508
Nyköping 507
Beijing 501
Wilmington 491
Ann Arbor 466
London 334
Helsinki 270
New York 267
The Dalles 243
Modena 233
Los Angeles 226
Milan 214
Ho Chi Minh City 204
Seoul 193
Chicago 160
Hanoi 148
Izmir 131
Princeton 130
San Diego 127
Sofia 123
Rome 122
Eugene 114
Lauterbourg 99
Columbus 94
Buffalo 90
Naples 78
São Paulo 75
Dallas 74
Redwood City 73
Jakarta 72
Moscow 65
Tokyo 63
Salt Lake City 57
Shanghai 57
Bologna 56
Munich 53
Toronto 52
Atlanta 48
Boardman 48
Des Moines 48
Orem 46
Mexico City 40
Brooklyn 38
Dublin 38
Falls Church 38
Tampa 38
Amsterdam 36
Dong Ket 36
Falkenstein 35
Florence 35
Frankfurt am Main 35
Phoenix 35
College Station 34
Reggio Emilia 34
Haiphong 33
San Francisco 31
Guangzhou 29
Turin 29
Boston 28
Chennai 28
Madrid 28
Paris 27
Saint Augustine 27
Turku 26
Istanbul 25
Rio de Janeiro 24
Nuremberg 23
Stockholm 23
Brussels 22
Elk Grove Village 22
Manchester 22
Parma 22
Belo Horizonte 21
Montreal 21
Kunming 20
Palermo 20
Tashkent 20
Hillsboro 19
Kent 19
Nanjing 19
Redondo Beach 19
Warsaw 19
Baghdad 18
Da Nang 18
Johannesburg 18
Totale 24.388
Nome #
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 1.315
A 96-well assay for uronic acid carbazole reaction 645
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 644
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 525
Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum 410
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 391
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 387
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 385
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 377
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 375
Comparison of CPC and CETAB extractive procedures for quantification and characterization of human urinary glycosaminoglycans 373
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 370
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 366
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 364
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 362
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 357
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 350
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 347
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 339
Electrophoretic approaches to the analysis of complex polysaccharides 337
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 329
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 328
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 328
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 327
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 326
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 325
Glycosaminoglycan composition of the large freshwater mollusc bivalve Anodonta anodonta 322
Recent advances on separation and characterization of human milk oligosaccharides. 321
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 318
Glycosaminoglycan content in term and preterm milk during the first month of lactation 318
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 318
Quantitative and Qualitative Evaluation of ChondroitinSulfate in Dietary Supplements 317
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 316
Capillary electrophoresis of bacterial (lipo)polysaccharides 315
Composition and structure elucidation of human milk glycosaminoglycans 314
Isolation and structural characterization of chondroitin sulfate from bony fishes 313
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 312
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 309
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 306
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 302
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 301
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 300
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 299
Approccio globale alle mucopolisaccaridosi: applicazione di metodi altamente specifici per la diagnosi neonatale: risultati preliminari su campione di urina 296
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 296
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations 295
Capillary electrophoresis of complex natural polysaccharides 294
Electrophoresis for the analysis of heparin purity and quality. 293
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 293
Capillary electrophoresis of Biomolecules. Methods and Protocols. 292
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 290
Human milk glycosaminoglycans: the state of the art and future perspectives 288
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 286
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus 285
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 285
Glycosaminoglycan profiling as a novel pan-cancer minimally invasive systems biomarker. 285
Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults 285
High-throughput determination of urinary hexosamines for diagnosis of mucopolysaccharidoses by capillary electrophoresis and HPLC 284
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 284
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 281
PURIFICATION OF PROPOLIS FROM POLYCYCLIC AROMATIC HYDROCARBONS AND PRESERVATION OF ACTIVE POLYPHENOL COMPONENT. 281
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 278
Mobilization of osmotically inactive Na+ by growth and by dietary salt restriction in rats 278
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 275
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 273
High quality Green (Brazilian) propolis extracts characterized for active biomolecules exert epigenetic effects able to have a positive influence on cell oxidative stress 272
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 272
Separation of capsular polysaccharide K4 and defructosylated K4 derived disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE) 270
Structural characterization of chondroitin sulfate from sturgeon bone 268
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 268
Detection of submicrogram quantities of Escherichia coli lipopolysaccharides by agarose-gel electrophoresis 265
Human milk glycosaminoglycans. Handbook on dietary and nutritional aspects of human breast milk 265
Hodnocení chondroitin sulfátu v potravinových doplňcích v České republice (evaluation of chondroitin sulfate in Czech Republic food supplements) 264
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 262
Aortic valve leaflet glycosaminoglycans composition and modification in severe chronic valve regurgitation 257
Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis 255
Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains-All 253
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-aminoacridone 249
Effect of holder pasteurisation on human milk glycosaminoglycans 249
Breast Cyst Fluid Heparan Sulfate is Distinctively N-sulfated Depending on Apocrine or Flattened Type 248
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 248
Falsi positivi nella caratterizzazione dei glicosaminoglicani urinari in neonati a termine: crisi genitale del neonato? 248
Valutazione della risposta anticorpale IgG-mediata verso antigeni alimentari valutata mediante specifica e sensibile metodica ELISA 245
Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process 239
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. 236
Analytical performance of a standardized kit for mass spectrometry-based measurements of human glycosaminoglycans 236
Plasma glycosaminoglycan scores in early stage renal cell carcinoma 233
Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role 228
Microdetermination of chondroitin sulfate in normal human plasma by fluorophore-assisted carbohydrate electrophoresis (FACE) 228
Serum IgG responses to food antigens in the Italian population evaluated by highly sensitive and specific ELISA test 228
Chemical composition and antioxidant activity of propolis prepared in different forms and in different solvents useful for finished products 227
Plasma glycosaminoglycan scores in early stage renal cell carcinoma 226
High-throughput determination of urinary hexosamines in newborns of 2-3 days of age: application for the early diagnosis of mucopolysaccharidoses 225
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease 224
Structure and Activities of Natural Complex Polysaccharides 223
Selective removal of keratan sulfate in chondroitin sulfate samples by sequential precipitation with ethanol 222
Effect of 12 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated Mucopolysaccharidosis I patients 221
Determination of total and single species of all uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for a possible early diagnosis of mucopolysaccharidoses 217
Evaluation of chondroitin sulfate in Czech Republic dietary supplements 215
Structural characterization of chondroitin sulfate from Italian cheese Parmigiano Reggiano 213
Totale 31.079
Categoria #
all - tutte 126.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.613 0 0 0 119 47 131 126 92 267 208 325 298
2022/20232.643 273 297 195 240 251 391 81 305 294 33 115 168
2023/20241.836 82 100 74 269 398 157 166 198 66 60 111 155
2024/20255.585 199 68 82 391 1.072 749 442 425 630 209 565 753
2025/202610.296 514 318 775 1.048 1.667 857 1.160 599 1.041 953 733 631
2026/20272.877 324 540 799 1.214 0 0 0 0 0 0 0 0
Totale 35.443